Literature DB >> 4373393

Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus.

J S Youngner, G Keleti, D S Feingold.   

Abstract

Extraction of living Brucella abortus (strain 456) with aqueous ether yielded a nonviable, insoluble residue (Bru-Pel). When injected into mice, Bru-Pel was an effective, nontoxic interferon stimulus. Mice pretreated with Bru-Pel were protected against challenge with otherwise lethal doses of Semliki Forest virus. Significant protection was afforded when Bru-Pel was given as many as 7 days before virus challenge. Evidence is presented dealing with the complex nature of Bru-Pel and with the possibility that the antiviral activity of Bru-Pel may be associated not only with the production of interferon, but with a general increase in the level of nonspecific resistance in animals.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4373393      PMCID: PMC423087          DOI: 10.1128/iai.10.6.1202-1206.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  J S Youngner; S B Salvin
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

2.  Mechanism of resistance to virus challenge in mice infected with Brucella abortus.

Authors:  J J Muyembe; A Billiau; P De Somer
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  Influence of inhibitors of protein synthesis on interferon formation in mice.

Authors:  J S Youngner; W R Stinebring; S E Taube
Journal:  Virology       Date:  1965-12       Impact factor: 3.616

4.  Effect of Brucella abortus infection (vaccine strain 19BA) on Rauscher leukemia virus and L1210 leukemia in mice.

Authors:  T K Veskova; K L Chimishkyan; G J Sver-Moldavsky
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

5.  Interferon induction by detoxicated bacterial endotoxins.

Authors:  A S Galabov; S M Galabov
Journal:  Acta Virol       Date:  1973-11       Impact factor: 1.162

6.  Endotoxin-containing preparations of Brucella abortus: chemical studies.

Authors:  F F Badakhsh; J W Foster
Journal:  Am J Vet Res       Date:  1970-02       Impact factor: 1.156

7.  Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production.

Authors:  E De Clercq; P De Somer
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

8.  Interferon Induction and Resistance to Virus Infection in Mice Infected with Brucella abortus.

Authors:  A Billiau; E Schonne; L Eyckmans; P De Somer
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

9.  Interferon production by inactivated Newcastle disease virus in cell cultures and in mice.

Authors:  J S Youngner; A W Scott; J V Hallum; W R Stinebring
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

10.  Interferon induction in mice by lipopolysaccharide from Brucella abortus.

Authors:  G Keleti; D S Feingold; J S Youngner
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  5 in total

1.  Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

2.  Antiviral activity of Brucella abortus preparations; separation of active components.

Authors:  D S Feingold; G Keleti; J S Youngner
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  Antitumor activity of a Brucella abortus preparation.

Authors:  G Keleti; D S Feingold; J S Youngner
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.

Authors:  L A Glasgow; J L Crane; C J Schleupner; E R Kern; J S Youngner; D S Feingold
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

5.  Glucan-induced enhancement of host resistance to selected infectious diseases.

Authors:  J A Reynolds; M D Kastello; D G Harrington; C L Crabbs; C J Peters; J V Jemski; G H Scott; N R Di Luzio
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.